Levoleucovorin (Sandoz Inc)


Welcome to the PulseAid listing for the Levoleucovorin drug offered from Sandoz Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: Levoleucovorin
SUBSTANCE NAME: LEVOLEUCOVORIN CALCIUM PENTAHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-04-23
END MARKETING DATE: 0000-00-00


Levoleucovorin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLevoleucovorin from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 175(mg/17.5mL)
START MARKETING DATE: 2015-04-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-3201_646a224b-3380-4e5c-bad8-b70e04e66359
PRODUCT NDC: 0781-3201
APPLICATION NUMBER: ANDA203563

Other LEVOLEUCOVORIN CALCIUM PENTAHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sandoz IncLevoleucovorin